Related references
Note: Only part of the references are listed.Irisin, A Mediator of Muscle Crosstalk with Other Organs: From Metabolism Regulation to Protective and Regenerative Effects
Sedigheh Momenzadeh et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2022)
Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis
Wenyuan Gan et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)
FNDC5/Irisin: Physiology and Pathophysiology
Rashid Waseem et al.
MOLECULES (2022)
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
Angelo Armandi et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou et al.
DIAGNOSTICS (2022)
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Marcin Kosmalski et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Youn Huh et al.
JOURNAL OF OBESITY & METABOLIC SYNDROME (2022)
NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
BIOMOLECULES (2022)
The potential role of FNDC5/irisin in various liver diseases: awakening the sleeping beauties
Xiaoyu Wang et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2022)
Relation of serum irisin levels to obesity and non-alcoholic fatty liver disease
Gokcen Ulualan et al.
TURKISH JOURNAL OF PEDIATRICS (2022)
Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?
Priyanka Bhandari et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2022)
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
NAFLDin type 2 diabetes mellitus: Still many challenging questions
Simona Cernea et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Progress and Challenges in the Biology of FNDC5 and Irisin
Steffen Maak et al.
ENDOCRINE REVIEWS (2021)
The role of Irisin in multiorgan protection
Jun Ma et al.
MOLECULAR BIOLOGY REPORTS (2021)
Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Stefania Di Mauro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
Kenichiro Murayama et al.
DIAGNOSTICS (2021)
Utility of quantitative ultrasound in community screening for hepatic steatosis
Tu-Yung Chang et al.
ULTRASONICS (2021)
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Cyrielle Caussy et al.
CURRENT DIABETES REPORTS (2021)
Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
Rui Wang et al.
HORMONE AND METABOLIC RESEARCH (2021)
Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
Ajit Venniyoor et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in 2 Diabetes
Chenxi Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Aerobic exercise training-induced irisin secretion is associated with the reduction of arterial stiffness via nitric oxide production in adults with obesity
Kenichiro Inoue et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2020)
Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
Margalida Monserrat-Mesquida et al.
ANTIOXIDANTS (2020)
Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Jie Hu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2020)
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
Lars Lind et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult
Jayanta Paul
EGYPTIAN LIVER JOURNAL (2020)
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR
Mayada Metwally et al.
JOURNAL OF HEPATOLOGY (2019)
Effect of an acute exercise bout on immediate post-exercise irisin concentration in adults: A meta-analysis
J. Fox et al.
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2018)
Non-alcoholic fatty liver disease
James Maurice et al.
CLINICAL MEDICINE (2018)
Irisin in metabolic diseases
Stergios A. Polyzos et al.
ENDOCRINE (2018)
Non-alcoholic fatty liver disease and the interface between primary and secondary care
Emmanuel A. Tsochatzis et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Crosstalk between adipokines and myokines in fat browning
A. Rodriguez et al.
ACTA PHYSIOLOGICA (2017)
Physiology and role of irisin in glucose homeostasis
Nikolaos Perakakis et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury
Ken Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
Hui Peng et al.
NATURE COMMUNICATIONS (2017)
Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes
Mehrnoosh Shanaki et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M. Pappachan et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease
Nima Motamed et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The 148 M allele of the PNPLA3 is associated with plasma irisin levels in a population sample of Caucasian children: The PANIC Study
Anna Viitasalo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice
A. Rodriguez et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
ENDOCRINE (2015)
Irisin in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk
Grigorios Panagiotou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees
Eun Sung Choi et al.
PLOS ONE (2014)
The Structure of Irisin Reveals a Novel Intersubunit β-Sheet Fibronectin Type III (FNIII) Dimer IMPLICATIONS FOR RECEPTOR ACTIVATION
Maria A. Schumacher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong-Hoon Lee et al.
DIGESTIVE AND LIVER DISEASE (2010)